Pancreatic necrosis (PN) develops in 5% to 40% of patients with acute pancreatitis despite adequate treatment in the early phase. [1] [2] [3] [4] According to its location, PN can involve the pancreatic parenchyma, the peripancreatic parenchyma, or both. The most important factor in determining invasive treatment for PN is the presence of infection in the necrotic tissue. In cases with asymptomatic sterile PN, conservative management is the treatment of choice. However, when infection of PN is diagnosed by a positive aspirate, surgical necrosectomy has been the standard treatment for decades, based on the surgical dogma of removing the necrotic or dead tissue that is prone to infection. 3 From the 1980s to the early 1990s, infected PN had been regarded as an indication for immediate (within 24 hours) open surgical necrosectomy. 5 Since then, however, the concept of minimally invasive intervention and the notion of postponing intervention have been supported by a variety of studies. The latest evidence-based guidelines recommend a "staged," "minimally invasive," "step-up" approach for patients with infected necrotizing pancreatitis (Table 1) . 2, 3, 5, 6 In clinical practice, infected PN is diagnosed when gas is found in the necrotic collection in an imaging study and/or when unequivocal clinical signs of infection are present without another infectious focus (i.e., pneumonia). 3, 7 However, gas may also occur in the necrotic collection as a result of a fistula to the stomach/intestine. The use of fine needle-aspiration (FNA) for diagnostic purposes alone is limited in a state-of-the-art practice. Invasive intervention for infected PN should ideally be postponed until the necrotic collection has partially liquefied and has become encircled by a well-defined inflammatory wall. This walled-off necrosis (WON) usually occurs >4 weeks after the onset of necrotizing pancreatitis and can allow a safer and more effective intervention. 4, 7 The interventions used to drain and/or debride pancreatic/peripancreatic necrosis can be categorized into: (1) endoscopic approaches-endoscopic drainage with/ without subsequent endoscopic necrosectomy; (2) percutaneous approaches-percutaneous catheter drainage with/without subsequent minimally invasive retroperitoneal surgery (i.e., videoscopic-assisted retroperitoneal debridement or sinus tract endoscopy). Open surgical approaches are seldom used any more. The treatment modality is chosen by multidisciplinary consensus based on the center's expertise, facilities, and clinical experience, as well as the location of the PN.
In this issue of Gut and Liver, the Virginia Mason Medical
This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
Center group report on the outcomes of dual modality drainage in patients with symptomatic WON. 8 The authors also confirmed that patient outcomes were worse for infected WON than for symptomatic sterile WON. The dual modality drainage consisted of percutaneous drainage, followed immediately by placement of endoscopic transmural stent(s). This dual modality drainage may not be fully consistent with a typical step-up approach, because the second drainage in a step-up approach is generally performed only if no clinical improvement is seen 72 hours after first drainage. 5 Therefore, a strict requirement for dual modality drainage in all their patients with symptomatic WON is questionable. Moreover, endoscopic drainage may only be feasible in patients whose WON is located adjacent to the gastric or duodenal wall, and who are also in relatively good general condition and can tolerate a complex endoscopic procedure. Interestingly, the cases of symptomatic sterile WON (n=113) outnumbered the infected WON (n=93) in the Virginia Mason group's study population who underwent the invasive intervention. In cases with sterile WON, the invasive intervention can be performed only for unrelenting pain or obstruction of the gastric outlet, intestine, or bile duct, because catheter drainage of sterile WON has a potentially grave risk of introducing infection. 3, 5 The followings are plausible explanations for the relatively large number of sterile WON in this study population. First, selection biases may result from the eligibility for dual modality drainage. Second, referral biases may influence the study population. Third, the authors used a strict definition of infected WON based on the positive culture from fluid aspirates obtained during initial placement of drainage. However, the reported false negative rate of FNA in this setting can be up to 25%.
2,3,5,7
The authors reported a remarkably low mortality (2.4%/4.1%) in patients with symptomatic/infected WON who underwent the invasive intervention. The study population did not include early-phase deaths from acute necrotizing pancreatitis. Regarding the timing of mortality in severe acute pancreatitis, approximately half of these deaths occur within 14 days after the onset of symptoms due to organ failure. 9 Nevertheless, the favorable clinical outcomes of this study, from the aspects of low mortality and morbidity, are very notable, particularly as necrosectomy was not performed in any of their 211 patients with symptomatic WON. The reported rates of necrosectomy performed after catheter drainage varies markedly, from 0 to 100% among centers. 3 The timing of necrosectomy may vary among centers because the clinicians decide whether patients show any improvement in their clinical deterioration, and this may influence the necrosectomy rate. Dual modality drainage, which is a modified form of drainage procedures, may have the potential to decrease the need for necrosectomy. In addition, dual modality drainage may have the advantage of avoiding the occurrence of pancreaticocutaneous fistula. Chronic pancreaticocutaneous fistula is a feared complication of percutaneous drainage in the setting of necrotizing pancreatitis, especially with a disconnected pancreatic duct. 10 No chronic pancreaticocutaneous fistula developed in any patient who was treated with dual modality drainage, since this method provided an outlet for fluid passage into the gastrointestinal tract. Minimally invasive step-up approaches have markedly decreased the late-phase deaths of acute necrotizing pancreatitis, whereas modern critical care has apparently reduced the early- Step 2. Percutaneous catheter drainage*
Step 3. Additional drainage or upsizing of the catheter
Step 1. Conservative medical treatment (i.e., antibiotics)
Step 2. Endoscopic or percutaneous drainage
Step 4. Endoscopic necrosectomy or minimally invasive retroperitoneal necrosectomy
Step 5. Repeat procedure if necessary
Concept of the minimally invasive step-up approach · The step-up approach consists of an initial minimally invasive treatment, followed by a gradually more invasive procedure if the initial treatment fails.
· The aim is to delay intervention whenever possible.
· A minimally invasive treatment induces less intervention-related stress, whereas surgical necrosectomy induces a proinflammatory immune response and new-onset organ failure in patients who are already critically ill.
*Placement of a catheter before encapsulation may be debatable, but encapsulation is not "sine qua non" for catheter drainage.
phase deaths. Refined drainage procedures have further shifted the paradigm from necrosectomy to drainage. Refined drainage procedures include placement of multiple percutaneous catheters, catheter upsizing, multiple transluminal gateways, and dual modality techniques. Given the single-digit mortality rate already achieved for necrotizing pancreatitis, the drainage procedures may need more refinements to provide further decreases in factors such as the necrosectomy rate, number of procedures, procedure-related adverse events, length of hospitalization, duration of drainage, and hospital costs.
